Release Date: 15/07/10 11:16 Summary: Directors Interest Notice Appendix 3X Price Sensitive: No Download Document 32.04KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%